In this study we show that monoallelic 5.2-kb TYROBP deletion is a novel risk factor for AD, leading to twofold increased risk of AD and dementia with an earlier onset age in the monoallelic carriers when compared to non-carriers. Here, TYROBP is linked to dementia.